|
(Health-NewsWire.Net, April 30, 2015 ) This report provides comprehensive information on the current therapeutic developmental pipeline of NGM Biopharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Complete report on 2015 Product pipeline review of “NGM Biopharmaceuticals, Inc.” addiction with 13 market data tables and 4 figures, spread across 23 pages is available at http://www.rnrmarketresearch.com/ngm-biopharmaceuticals-inc-product-pipeline-review-2015-market-report.html . (This is a premium report price at US$1500 for a single user PDF license)
Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Scope:
• The report provides brief overview of NGM Biopharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
• The report reviews current pipeline of NGM Biopharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projects
• The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
• Special feature on out-licensed and partnered product portfolio
• The report summarizes all the dormant and discontinued pipeline projects
• Latest company statement
• Latest news and deals relating to the NGM Biopharmaceuticals, Inc.’s pipeline products
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Inquire for discount on this report at http://www.rnrmarketresearch.com/contacts/discount?rname=375204 .
Reasons to Buy:
• Evaluate NGM Biopharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
• Assess the growth potential of NGM Biopharmaceuticals, Inc. in its therapy areas of focus
• Identify new drug targets and therapeutic classes in the NGM Biopharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
• Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
• Develop strategic initiatives by understanding the focus areas of NGM Biopharmaceuticals, Inc. and exploit collaboration and partnership opportunities
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Plan mergers and acquisitions effectively by identifying the most promising pipeline of NGM Biopharmaceuticals, Inc.
More reports on Biopharmaceuticals :
Rodos BioTarget GmbH – Product Pipeline Review – 2015
This report provides comprehensive information on the current therapeutic developmental pipeline of Rodos BioTarget GmbH’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.
Complete report is available at http://www.rnrmarketresearch.com/rodos-biotarget-gmbh-product-pipeline-review-2015-market-report.html .
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
RnR Market Research
Ritesh Tiwari
+ 1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
|
